Trial Profile
A Single Arm Single Centre Study To Investigate Safety And Efficacy Of Sildenafil In Near Term And Term Newborns With Persistent Pulmonary Hypertension Of The Newborn (PPHN)
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Pulmonary hypertension
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
- 09 May 2014 New trial record
- 22 Aug 2012
- 07 Jun 2011